Feedback / Questions
VENT-03 - Ventus Therap
https://www.businesswire.com/news/home/20251209988664/en/Ventus-Therapeutics-Announces-First-Patient-Dosed-in-Phase-2-Clinical-Trial-of-VENT-03-a-Novel-Small-Molecule-cGAS-Inhibitor-in-Patients-with-Lupus
Dec 10, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next